Drugs that contain Methyl Aminolevulinate Hydrochloride
1. Metvixia patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6034267 | GALDERMA LABS LP | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Mar, 2016
(8 years ago) | |
Market Authorisation Date: 27 July, 2004
Treatment: Treatment of actinic keratoses by photodynamic therapy
Dosage: CREAM;TOPICAL
More Information on Dosage
METVIXIA family patents
